Publications
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 2nd part Summary2019 | Faculty of Medicine in Pilsen
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Patient with three EGFR mutations - gradual development of resistance to previous targeted treatment2018 | Faculty of Medicine in Pilsen, Faculty of Science
- Influence of expression of selected genes encoding proteins and microRNA on the risk of stage 1 pulmonary adenocarcinoma relapse2017 | Faculty of Medicine in Pilsen
- Crizotinib - Still "gold standard" for patients with pulmonary adenocarcinoma with ALK translocation?2017 | Faculty of Medicine in Pilsen
- Systemic therapy of lung adenocarcinoma2016 | Faculty of Medicine in Pilsen
- Current Two EGFR Mutations in Lung Adenocarcinoma - Case Report2015 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically treated patients with non-small cell lung cancer2014 | Faculty of Medicine in Pilsen
- ROS1 - another potencional target of our patients2014 | Faculty of Medicine in Pilsen
- Lymphangioleiomyomatose – the way inwards cells2013 | Faculty of Medicine in Pilsen
Loading network view...